Reich, Patrick

Profile picture
Instructor in Pediatrics, Infectious Diseases
Infectious Diseases

phone: (314) 454-6050

Clinical Interests

Dr. Reich’s clinical interests include the evaluation and management of general pediatric infectious diseases, treatment and prevention of healthcare-associated infections, treatment of multi-drug-resistant bacterial infections, and treatment of infections in immunocompromised hosts. As Dr. Reich is also passionate about medical student and resident education, he currently serves as an Associate Program Director for the pediatric residency program. He is also the Medical Director of Infection Prevention at St. Louis Children's Hospital. His research interests include the epidemiology and prevention of pediatric healthcare-associated infections, particularly with regards to methicillin-resistant Staphylococcus aureus (MRSA) infections.


  • BA, summa cum laude, St. Louis University2007
  • MD, St. Louis University School of Medicine2011
  • MSCI, Washington University School of Medicine2019


  • Pediatric Residency, Washington University School of Medicine2011 - 2014
  • Chief Residency, Washington University School of Medicine2014 - 2015
  • Infectious Diseases Fellowship, Washington University School of Medicine2015 - 2018
  • Society for Healthcare Epidemiology Training Course in Healthcare Epidemiology2017 - 2017
  • Educational Skills Program, Washington University School of Medicine2019 - 2019

Licensure and Board Certification

  • 2014 - PresGeneral Pediatrics, American Board of Pediatrics
  • 2014 - PresMO, Physician and Surgeon
  • 2019 - PresPediatric Infectious Diseases

Honors and Awards

  • Washington University Department of Pediatrics Commitment to Teaching2019
  • Washington University Department of Pediatrics Unsung Hero Award2021

Recent Publications view all (8)

  1. A Case Series of Kawasaki Disease in Children With Sickle Cell Disease J Pediatr Hematol Oncol. 2021. doi:10.1097/MPH.0000000000002308  PMID:34486560 
  2. Factors associated with progression to infection in methicillin-resistant Staphylococcus aureus-colonized, critically ill neonates J Perinatol. 2021. doi:10.1038/s41372-021-00944-8  PMID:PMC7917959 
  3. Delayed Development of Coronary Artery Dilitation in Suspected Severe Acute Respiratory Syndrome Coronavirus 2 Multisystem Inflammatory Syndrome: More Research Needed Crit Care Explor. 2020. doi:10.1097/CCE.0000000000000236  PMID:33063036 
  4. Staphylococcus aureus antibiotic susceptibility patterns in pediatric atopic dermatitis Pediatr Dermatol. 2019. PMID:31124167 
  5. Carriage of the Toxic Shock Syndrome Toxin Gene by Contemporary Community-Associated Staphylococcus aureus Isolates. J Pediatric Infect Dis Soc. 2018. PMID:30285124 
  6. Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole J Pediatric Infect Dis Soc. 2018. PMID:29522137 
  7. Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome Clin Kidney J. 2016. PMID:27478599 
  8. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and patient safety challenge. Clin Microbiol Infect. 2016;22(7):645.e1-8. PMCID:PMC4987169  PMID:27126609 
Last updated: 09/28/2021
© 2021 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130